Validation of International Working Group response criteria in higher‐risk myelodysplastic syndromes: A report on behalf of the MDS Clinical Research Consortium

The utility of the International Working Group (IWG) 2006 response criteria for myelodysplastic syndromes (MDS) as a surrogate endpoint for outcomes is unclear. We assessed the validity of the IWG 2006 response criteria in a large cohort of higher‐risk MDS patients (pts) treated at centers from the...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Cancer Med
Prif Awduron: Komrokji, Rami S., Al Ali, Najla H, Sallman, David, Padron, Eric, DeZern, Amy E., Barnard, John, Roboz, Gail J., Garcia‐Manero, Guillermo, List, Alan, Steensma, David P., Sekeres, Mikkael A.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: John Wiley and Sons Inc. 2020
Pynciau:
Clinical Cancer Research
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7877342/
https://ncbi.nlm.nih.gov/pubmed/33350168
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.3608
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg